News & Updates

Case study: Lessons on managing invasive mould disease in the ICU

05 Aug 2023 by

In conjunction with the 42nd International Symposium on Intensive Care and Emergency Medicine (ISICEM), Pfizer sponsored a symposium addressing the complex challenges of managing invasive mould disease (IMD) in the intensive care unit (ICU), emphasizing the importance of a proactive mindset among intensivists. Using a real-life patient case study, Dr Paula Ramirez from La Fe University and Polytechnic Hospital, Valencia, Spain highlighted the significance of early suspicion, swift diagnosis, and timely treatment in critically ill patients with IMD. Professor Gennaro De Pascale from the Catholic University of the Sacred Heart, Rome, Italy discussed effective management strategies and the clinical evidence for various antifungals in treating IMD in critically ill patients.

Case study: Lessons on managing invasive mould disease in the ICU

05 Aug 2023

Staphylococcus epidermidis infections linked to ICU septic shocks

04 Aug 2023

Bloodstream infections caused by Staphylococcus epidermidis (SE-BSI) may lead to septic shock in patients admitted to intensive care unit (ICU), according to a study.

Staphylococcus epidermidis infections linked to ICU septic shocks

04 Aug 2023

Hybrid, bismuth quadruple therapies superior to high-dose dual therapy for H pylori eradication

03 Aug 2023

In the first-line treatment of Helicobacter pylori (H pylori) infection, 14-day hybrid therapy and 10-day bismuth quadruple therapy demonstrate superiority over 14-day high-dose dual therapy, reports a Taiwan study. However, high-dose therapy results in fewer adverse events than hybrid bismuth quadruple therapies.

Hybrid, bismuth quadruple therapies superior to high-dose dual therapy for H pylori eradication

03 Aug 2023

Fertility treatment may be less effective in COVID-infected couples

03 Aug 2023 by

Couples infected with SARS-CoV-2 while receiving assisted reproductive technology (ART) treatment had lower quality embryo and blastocyst rates compared with uninfected couples in a multicentre cohort study.

Fertility treatment may be less effective in COVID-infected couples

03 Aug 2023

Original New Drug Application Approvals by US FDA (16-31 July 2023)

02 Aug 2023

New drug applications approved by US FDA as of 16-31 July 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 July 2023)

02 Aug 2023

PPI use carries increased risk of pneumonia

01 Aug 2023

Individuals who use proton pump inhibitors (PPIs) appear to be at heightened risk of pneumonia, as reported in a study.

PPI use carries increased risk of pneumonia

01 Aug 2023

COVID-19 vaccines may elicit cross-reactive T-cell responses for long-term protection

01 Aug 2023 by

Researchers from the Chinese University of Hong Kong (CUHK) have reported that two doses of either mRNA-based BNT162b2 or inactivated CZ02 vaccine elicit cross-reactive T-cell responses. Identification of vaccine-induced memory T cells indicates potential long-term protection with COVID-19 vaccines.

COVID-19 vaccines may elicit cross-reactive T-cell responses for long-term protection

01 Aug 2023

Physical activity good for COPD

29 Jul 2023

Initiation of moderate-to-vigorous physical activity (MVPA) can help lower the risks of mortality and severe exacerbations for patients with chronic obstructive pulmonary disease (COPD), as reported in a study.

Physical activity good for COPD

29 Jul 2023

HPV vaccination in Hong Kong: Misconceptions, myths and money

29 Jul 2023 by

A survey of 851 parents in Hong Kong finds that awareness and acceptance of human papillomavirus (HPV) vaccination for children are lower among parents of boys vs girls, and that main reasons for vaccine hesitancy are concerns about vaccine side effects and the belief that their child is too young to be vaccinated against HPV.

HPV vaccination in Hong Kong: Misconceptions, myths and money

29 Jul 2023

Intravaginal medical device a promising standalone treatment for nonspecific vaginitis

26 Jul 2023 by

In women with nonspecific vaginitis, treatment with a medical device that uses vaginal ovules not only helps alleviate symptoms but also works to restore the normal pH and reduce signs of vaginal inflammation, as reported in a study.

Intravaginal medical device a promising standalone treatment for nonspecific vaginitis

26 Jul 2023

News & Updates

Filter by Specialty:

Specialty:

Case study: Lessons on managing invasive mould disease in the ICU

Case study: Lessons on managing invasive mould disease in the ICU

Staphylococcus epidermidis infections linked to ICU septic shocks

Staphylococcus epidermidis infections linked to ICU septic shocks

Hybrid, bismuth quadruple therapies superior to high-dose dual therapy for H pylori eradication

Hybrid, bismuth quadruple therapies superior to high-dose dual therapy for H pylori eradication

Fertility treatment may be less effective in COVID-infected couples

Fertility treatment may be less effective in COVID-infected couples

Original New Drug Application Approvals by US FDA (16-31 July 2023)

Original New Drug Application Approvals by US FDA (16-31 July 2023)

PPI use carries increased risk of pneumonia

PPI use carries increased risk of pneumonia

COVID-19 vaccines may elicit cross-reactive T-cell responses for long-term protection

COVID-19 vaccines may elicit cross-reactive T-cell responses for long-term protection

Physical activity good for COPD

Physical activity good for COPD

HPV vaccination in Hong Kong: Misconceptions, myths and money

HPV vaccination in Hong Kong: Misconceptions, myths and money

Intravaginal medical device a promising standalone treatment for nonspecific vaginitis

Intravaginal medical device a promising standalone treatment for nonspecific vaginitis